
ZolgensmaWhat is it and why is the price so high?The drug, first approved by the US Food and Drug Administration on May 24, 2019, was approved by the UK's National Health Service (NHS) on March 9, 2020.The drug is manufactured by Novartis Gene Therapies, a Swiss bio-pharmaceutical...